Top compounds associated with response to RNF165


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.041 0.3
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.033 0.3
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.3
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.3
mRNA AEW541 CCLE pan-cancer AAC -0.049 0.3
mRNA BMS-195614 CTRPv2 pan-cancer AAC -0.045 0.3
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.033 0.3
mRNA KHS101 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA foretinib CTRPv2 pan-cancer AAC 0.041 0.3
mRNA regorafenib CTRPv2 pan-cancer AAC 0.044 0.3
Download CSV